Default Image
10, Mar 2026
Beat the Heat with Dr.Jart plus Cicapair This Summer

When summer arrives, so do common skin concerns, redness, irritation, and sensitivity triggered by heat, humidity, and environmental stressors. Meet the Dr.Jart+ Cicapair Intensive Soothing Repair Serum and Gel Cream, the ultimate duo designed to keep skin calm, balanced, and comfortable through the hottest days.

Beat the Heat with Dr.Jart+ Cicapair This Summer

Powered by the soothing strength of Centella Asiatica (Cica) and Niacinamide, the Cicapair range is crafted especially for sensitive and redness-prone skin. Together, these ingredients work to calm irritation, visibly reduce redness, and reinforce the skin barrier, helping skin stay resilient even in challenging weather conditions.

The Cicapair Intensive Soothing Repair Gel Cream, is a refreshing, lightweight gel-cream that delivers cooling hydration without feeling heavy or sticky making it perfect for humid summer days. Infused with Niacinamide, it helps keep skin feeling fresh and balanced while visibly calming redness. With the added power of Cica, it works to repair and strengthen the skin barrier while leaving a breathable finish ideal for hot weather.

Complementing the moisturizer is the Cicapair Intensive Soothing Repair Serum, a potent formula enriched with Cica Complex, peptides, and allantoin that helps rapidly support the skin’s barrier recovery. Dermatologist-tested and suitable for sensitive skin, the serum helps stabilize stressed skin while boosting barrier repair.

Clinical results highlight the serum’s effectiveness, showing a 126% boost in skin barrier repair within just one hour, along with an instant reduction in visible redness.

Together, the Cicapair Intensive Soothing Repair Serum and Gel Cream form the perfect summer skincare pairing working to soothe, strengthen, and protect sensitive skin while keeping it calm, hydrated, and comfortable throughout the season.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Max Healthcare Announces Entry into Pune with a 450-Beds Hospital, Investment of over INR 1000 Cr

Mumbai, Dec 19:- Max Healthcare Institute Ltd. one of the largest private sector healthcare services companies in India, today announced…

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial

Study will advance into expanded patient populations with myelodysplastic syndrome (MDS) and myelofibrosis (MF) SOUTH SAN FRANCISCO, Calif., April 15, 2026: CERo Therapeutics…

International Rare Disease Day 2026 Observed on 22nd February 2026 at SGPGI, Lucknow

New Delhi, Feb 24:  International Rare Disease Day was observed with great commitment and solidarity on 22nd February 2026 through…